Role of mitochondria in the etiology and pathogenesis of Parkinson's disease
- PMID: 7599219
- DOI: 10.1016/0925-4439(95)00038-6
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease
Abstract
We discuss the etiology and pathogenesis of Parkinson's disease (PD). Our group and others have found a decrease in complex I of the mitochondrial electron transfer complex in the substantia nigra of patients with PD; in addition, we reported loss of the alpha-ketoglutarate dehydrogenase complex (KGDHC) in the substantia nigra. Dual loss of complex I and the KGDHC will deleteriously affect the electron transport and ATP synthesis; we believe that energy crisis is the most important mechanism of nigral cell death in PD. Oxidative stress has also been implicated as an important contributor to nigral cell death in PD, but we believe that oxidative stress is a secondary phenomenon to respiratory failure, because respiratory failure will increase oxygen free-radical formation and consume glutathione. The primary cause of mitochondrial respiratory failure has not been elucidated yet, but additive effect of environmental neurotoxins in genetically predisposed persons appears to be the most likely possibility.
Similar articles
-
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Free Radic Biol Med. 2013. PMID: 23743292 Review.
-
Iron-dependent enzymes in Parkinson's disease.J Neural Transm Suppl. 1995;46:157-64. J Neural Transm Suppl. 1995. PMID: 8821051
-
[Parkinson's disease; etiology and animal model].No To Shinkei. 1991 Aug;43(8):703-11. No To Shinkei. 1991. PMID: 1931253 Review. Japanese. No abstract available.
-
Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.Ann Neurol. 1992;32 Suppl:S116-24. doi: 10.1002/ana.410320720. Ann Neurol. 1992. PMID: 1510369 Review.
-
New insights into the cause of Parkinson's disease.Neurology. 1992 Dec;42(12):2241-50. doi: 10.1212/wnl.42.12.2241. Neurology. 1992. PMID: 1461374 Review.
Cited by
-
An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease.Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10918-23. doi: 10.1073/pnas.191107398. Epub 2001 Sep 4. Proc Natl Acad Sci U S A. 2001. PMID: 11535810 Free PMC article.
-
Effects of silica nanoparticle exposure on mitochondrial function during neuronal differentiation.J Nanobiotechnology. 2017 Jul 4;15(1):49. doi: 10.1186/s12951-017-0284-3. J Nanobiotechnology. 2017. PMID: 28676089 Free PMC article.
-
A reversible state of hypometabolism in a human cellular model of sporadic Parkinson's disease.Nat Commun. 2023 Nov 23;14(1):7674. doi: 10.1038/s41467-023-42862-7. Nat Commun. 2023. PMID: 37996418 Free PMC article.
-
Genotyping Parkinson disease-associated mitochondrial polymorphisms.Clin Med Res. 2004 May;2(2):99-106. doi: 10.3121/cmr.2.2.99. Clin Med Res. 2004. PMID: 15931342 Free PMC article.
-
Laboratory approach to mitochondrial diseases.J Physiol Biochem. 2001 Sep;57(3):267-84. doi: 10.1007/BF03179820. J Physiol Biochem. 2001. PMID: 11800289 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical